Petros Pharmaceuticals News

Petros Pharmaceuticals | 8-K: Current report

17:11 ET

Petros Pharmaceuticals | PRE 14A: Preliminary proxy statements relating to merger or acquisition

Oct 15 17:24 ET

Petros Pharmaceuticals | 8-K: Current report

Oct 4 17:19 ET

Petros Pharmaceuticals | 8-K: Current report

Sep 19 16:10 ET

Petros Pharmaceuticals | S-3: Registration statement for specified transactions by certain issuers

May 3 17:07 ET

Petros Pharmaceuticals | 8-K: Current report

Mar 22 16:36 ET

Petros Pharmaceuticals | 8-K: Current report

Jan 12 00:00 ET

Petros Pharmaceuticals | 8-K: Current report

Dec 29, 2023 00:00 ET

Petros Pharmaceuticals | 8-K: Current report

Dec 28, 2023 00:00 ET

Petros Pharmaceuticals | DEF 14A: Definitive information statements

Nov 30, 2023 16:05 ET

Petros Pharmaceuticals | NT 10-Q: Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB

Nov 15, 2023 17:00 ET

Petros Pharmaceuticals | 8-K: Current report

Oct 2, 2023 08:00 ET

Petros Pharmaceuticals | S-3/A: Registration statement for specified transactions by certain issuers (Amendment)

Sep 15, 2023 17:16 ET

Petros Pharmaceuticals | 8-K: Current report

Sep 15, 2023 16:22 ET

Petros Pharmaceuticals | DEF 14A: Definitive information statements

Aug 25, 2023 17:08 ET

Petros Pharmaceuticals | 8-K: Current report

Aug 15, 2023 17:03 ET

Petros Pharmaceuticals | PRE 14A: Preliminary proxy statements relating to merger or acquisition

Aug 15, 2023 17:01 ET

Petros Pharmaceuticals | S-3: Registration statement for specified transactions by certain issuers

Aug 11, 2023 16:31 ET

Petros Pharmaceuticals | 8-K: Current report

Jul 13, 2023 16:41 ET

Petros Pharmaceuticals | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Dec 22, 2022 17:03 ET